Laidlaw was the investment banker of Relmada Therapeutics and its placement agent in December of 2011 and May of 2014. During Relmada's merger with Camp Nine, Inc., Laidlaw served as its financial advisor. However, in 2015 a dispute arose between the two parties after Relmada requested Laidlaw to organize a non-deal show to attract new […]
SOURCE: culturebytes.org at 06:35PM on October 8, 2016